Month: April 2021

WATERTOWN, Mass., April 05, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will participate in a fireside chat and one-on-one investor meetings at the virtual 20th Annual Needham Healthcare Conference to be held April 12-15, 2021. Details on the presentation can be found below. Date: Tuesday, April 13Fireside chat time: 3:00 p.m. ETWebcast: Click Here An archived webcast will also be available in the Investors & Media section of the company’s website at www.selectabio.com. About Selecta Biosciences, Inc.Selecta Biosciences Inc. (NASDAQ: SELB) is leveraging its clinically...

IRVINE, Calif., April 05, 2021 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the enrollment of the first high-risk pulmonary embolism (“PE”) patient in the FlowTriever for Acute Massive Pulmonary Embolism study (“FLAME”). One in 20 PE diagnoses is categorized as high-risk and these are associated with a mortality rate of up to 40% at 90 days. The first FLAME patient was enrolled at the Penn Presbyterian Hospital & Hospital of the University of Pennsylvania (“HUP”) by co-principal investigators Dr. Sameer J. Khandhar and Dr. Jay S. Giri. “We are pleased to be the first site to enroll a patient in FLAME,” said Dr. Khandhar, Interventional Cardiologist,...

BOSTON and ROCKVILLE, Md., April 05, 2021 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointment of Jessie M. English, Ph.D. to its Board of Directors. Dr. English is a proven biotechnology leader and brings over 20 years of experience in oncology research as well as business and leadership development. “Jessie’s experience in building vibrant, data-driven companies will serve as an important asset to our Board of Directors as we continue to build Sensei Bio’s research capabilities and pipeline. I am excited to welcome her to our Board of Directors at this critical time in Sensei’s development. Her expertise in both oncology drug discovery and business development will...

PEARL RIVER, N.Y., April 05, 2021 (GLOBE NEWSWIRE) — Sterling National Bank, the wholly-owned operating bank subsidiary of Sterling Bancorp (NYSE: STL), today announced a Banking as a Service (BaaS) agreement with Rho Technologies, the fintech company behind Rho Business Banking. Rho Technologies is a digital platform that provides companies with a suite of commercial banking and financial software solutions. Sterling will provide Rho with a holistic package of wholesale banking solutions to support their rapid expansion and accelerate customer growth. This collaboration is a multi-service partnership that combines Sterling’s product, operational and regulatory expertise with Rho’s sophisticated technology and product capabilities. This collaboration marks the latest in a series of strategic partnerships and digital technology investments...

– Data add to growing body of pre-clinical evidence demonstrating that VIR-7831 maintains activity against all known circulating variants of concern – – Plasma from vaccinated individuals and several therapeutic monoclonal antibodies showed a reduction in neutralization potency against the California variant – SAN FRANCISCO, April 05, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced new preclinical research demonstrating the ability of VIR-7831, the company’s investigational SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) monoclonal antibody (mAb), to maintain its neutralizing activity against a mutation in the receptor binding domain (RBD) of SARS-CoV-2, called L452R, which is found in the California variant (B.1.427/B.1.429). Study results also demonstrate that the L452R mutation reduced...

St. Louis, April 05, 2021 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today announced that Christopher (Chris) L. Tucker has been named Senior Vice President and Chief Financial Officer, effective April 19, 2021. Mr. Tucker succeeds Gary E. Muenster who, on December 7, 2020 announced his plans to retire after 31 successful years with the Company, with the past 18 years serving as CFO. After Mr. Tucker’s start date, Mr. Muenster will remain as a strategic advisor supporting the executive management team and Board of Directors during the transition and until the onboarding process is complete. Mr. Tucker worked at Emerson (NYSE: EMR) for the past 24 years most recently serving as Vice President and Chief Financial Officer of Emerson’s Commercial & Residential Solutions (C&R) reporting segment...

TEL AVIV, Israel, April 05, 2021 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, today announced that it has scheduled its earnings call to discuss its first quarter 2021 financial results. Conference Call Details Radware management will host a call on Wednesday, May 5, 2021 at 8:30 am ET to discuss its first quarter 2021 results and the company’s outlook for the second quarter of 2021. Participants are advised to join the call early to avoid delayed entries. US: 833-968-2213 (toll free)International: +1 778-560-2898Conference ID: 5036077 The call will be webcast live on the Company’s website at http://www.radware.com/ir/investor-events/.A replay will be available for 2 days, starting 2 hours after the end of the call, on telephone number +1-416-621-4642...

MALVERN, Pa., April 05, 2021 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH) announced today that its Annual Meeting of Stockholders will be held at 9:00 a.m., U.S. eastern time, on Tuesday, May 25, 2021. Vishay has adopted a virtual annual meeting in 2021 due to health, transportation, and other logistical issues arising from the COVID-19 pandemic. The annual meeting will be accessible to stockholders via the Internet at www.virtualshareholdermeeting.com/VSH2021. United States Securities and Exchange Commission rules allow the Company to mail a notice to its stockholders advising that its proxy statement, annual report to stockholders, electronic proxy card and related materials are available for viewing, free of charge, on the Internet. Stockholders may then access these materials and vote over the Internet or request...

Former Coinbase Director of Engineering joins as Company’s third independent director Silver Spring, MD, April 05, 2021 (GLOBE NEWSWIRE) — BTCS Inc. (OTCQB: BTCS) (“BTCS” or the “Company”), a digital asset and blockchain technology focused company, today announced the appointment of Litecoin creator Charlie Lee to its Board of Directors as its newest independent member. “We are honored to welcome Charlie Lee to our board,” stated Charles Allen, Chief Executive Officer of BTCS. “A true innovator and visionary in the blockchain space, his decision to join our board is a strong vote of confidence in our multi-faceted strategy. We look forward to working closely together to execute on our vision for long-term success.” Mr. Lee, a computer scientist best known as the creator of Litecoin, the ninth-ranked cryptocurrency globally with...